Exophthalmos is a protrusion of the eyeball from the eye socket that can affect one or both eyes. The condition, commonly associated with abnormal thyroid levels found in Graves' disease, can become quite serious, causing lasting visual impairment.
ICD-10 Code for Unspecified exophthalmos- H05. 20- Codify by AAPC.
ICD10 codes matching "Graves' Disease"E05.0 Thyrotoxicosis with diffuse goiter.E05.00 Thyrotoxicosis with diffuse goiter without thyrotoxic crisis or storm.E05.01 Thyrotoxicosis with diffuse goiter with thyrotoxic crisis or storm.
00: Thyrotoxicosis with diffuse goiter without thyrotoxic crisis or storm.
Proptosis can describe any organ that is displaced forward, while exophthalmos refers to only the eyes. Proptosis can include any directional forward displacement.
Exophthalmos, also known as proptosis, is the medical term for bulging or protruding eyeballs. It can affect 1 or both eyes and is most often caused by thyroid eye disease.
90 for Thyrotoxicosis, unspecified without thyrotoxic crisis or storm is a medical classification as listed by WHO under the range - Endocrine, nutritional and metabolic diseases .
2012 ICD-9-CM Diagnosis Code 242.00 : Toxic diffuse goiter without mention of thyrotoxic crisis or storm.
What are the symptoms of Graves' disease?weight loss, despite an increased appetite.rapid or irregular heartbeat.nervousness, irritability, trouble sleeping, fatigue.shaky hands, muscle weakness.sweating or trouble tolerating heat.frequent bowel movements.an enlarged thyroid gland, called a goiter.
The 2022 edition of ICD-10-CM H05. 20 became effective on October 1, 2021. This is the American ICD-10-CM version of H05.
00 for Thyrotoxicosis with diffuse goiter without thyrotoxic crisis or storm is a medical classification as listed by WHO under the range - Endocrine, nutritional and metabolic diseases .
E05. 90 - Thyrotoxicosis, unspecified without thyrotoxic crisis or storm | ICD-10-CM.
Graves' disease is an immune system disorder that results in the overproduction of thyroid hormones (hyperthyroidism). Although a number of disorders may result in hyperthyroidism, Graves' disease is a common cause. Thyroid hormones affect many body systems, so signs and symptoms of Graves' disease can be wide ranging.
Graves' disease may present only with subclinical hyperthyroidism (normal total and free T3 and T4 with suppressed TSH levels).
Graves' disease is a lifelong (chronic) condition. However, treatments can keep your thyroid hormone levels in check. Medical care may even make the disease temporarily go away (remission).
Some patients with apparent Graves' disease do not have an autoimmune thyroid disorder. One of the most common causes of hyperthyroidism is Graves' disease, an autoimmune process in which the patient's immune cells make antibodies against the thyroid stimulating hormone (TSH) receptor on the thyroid gland cells.
Exophthalmos (also called exophthalmus, exophthalmia, proptosis, or exorbitism) is a bulging of the eye anteriorly out of the orbit. Exophthalmos can be either bilateral (as is often seen in Graves' disease) or unilateral (as is often seen in an orbital tumor).
This is the official approximate match mapping between ICD9 and ICD10, as provided by the General Equivalency mapping crosswalk. This means that while there is no exact mapping between this ICD10 code H05.242 and a single ICD9 code, 376.31 is an approximate match for comparison and conversion purposes.
These autoantibodies can also affect the eyes (graves ophthalmopathy) and the skin (graves dermopathy). A condition usually caused by excessive production of thyroid hormone and characterized by an enlarged thyroid gland. Exophthalmos occurring in association with goiter; hyperthyroidism with protrusion of the eyeballs.
Exophthalmos occurring in association with goiter; hyperthy roidism with protrusion of the eyeballs. Hyperthyroidism associated with diffuse hyperplasia of the thyroid gland (goiter), resulting from production of antibodies that are directed against the thyrotropin receptor complex of the follicular epithelial cells.
The 2022 edition of ICD-10-CM E05.0 became effective on October 1, 2021.
Thyrotoxicosis [hyperthyroidism] Clinical Information. A common form of hyperthyroidism with a diffuse hyperplastic goiter. It is an autoimmune disorder that produces antibodies against the thyroid stimulating hormone receptor.
Exophthalmos (also called exophthalmus, exophthalmia, proptosis, or exorbitism) is a bulging of the eye anteriorly out of the orbit. Exophthalmos can be either bilateral (as is often seen in Graves' disease) or unilateral (as is often seen in an orbital tumor).
This is the official exact match mapping between ICD9 and ICD10, as provided by the General Equivalency mapping crosswalk. This means that in all cases where the ICD9 code 376.30 was previously used, H05.20 is the appropriate modern ICD10 code.
A Wikipedia review on "Graves' ophthalmopathy" (Last modified July 20, 2015) states that "Eyelid surgery is the most common surgery performed on Graves ophthalmopathy patients. Lid-lengthening surgeries can be done on upper and lower eyelid to correct the patient’s appearance and the ocular surface exposure symptoms.
Sometimes combinations of the following procedures are used: Elevating the head at night, cool compresses, sunglasses, lubricating eyedrops, or prisms for glasses;
Allograft. Aetna considers the use of banked human tissue graft (e.g., Alloderm) to elevate the lower eyelids in members with lower eyelid retraction associated with Graves ophthalmopathy experimental and investigational because there is insufficient evidence to support this approach.
Aetna considers orbital decompression surgery, and eye muscle surgery or eyelid surgery (e.g., marginal myotomy of levator palpebrae muscle, lateral tarsal canthoplasty, mullerectomy (resection of the Müller muscle), eyelid spacer grafts, and recession of the lower eyelid retractors) medically necessary for members with severe Graves' ophthalmopathy (especially individuals with marked proptosis and optic neuropathy) when both of the following measures have not been successful:
Graves' ophthalmopathy generally causes the eyelids to open more widely. The front surface of the eyeball becomes exposed beyond the eyelid and causes excessive tearing and discomfort. Lid retraction may be improved by orbital decompression, especially the lower lid. However, the backward and downward movement of the globe following decompression may accentuate upper lid retraction. Surgical re-positioning (recession) of the upper lid retractors may have to be performed as an adjunct.
Aetna considers the following interventions experimental and investigational for the treatment of Graves' ophthalmopathy because their effectiveness for this indication has not been established (not an all-inclusive list):
Rau and colleagues (2018) noted that Graves' disease is a common autoimmune inflammatory condition of the thyroid. About 25 % of affected patients also develop orbital symptoms like exophthalmos, proptosis and diplopia – called Graves' Ophthalmopathy. Not all patients respond well to the standard therapy of systemic glucocorticoid administration. The inflammatory swelling of the intra-orbital muscles can lead to pressure-induced damage of the optic nerve. Orbital decompression surgery is a therapeutic option for these patients with varying success. Other symptoms like the extreme malposition of the ocular globe are poorly addressed by decompression surgery and demand for different therapeutic approaches. These researchers presented the case of a 46-year old patient with an acute exacerbation of Graves' ophthalmopathy. Clinically apparent was a convergent strabismus fixus with severe hypotropia of both eyes. The patient suffered from attacks of heavy retro-bulbar pain and eyesight deteriorated dramatically. Since neither systemic glucocorticoid therapy nor orbital decompression surgery had helped to halt the progress of the disease, a decision was made in favor of the surgical release and re-positioning of the inferior and medial rectus muscle as a final therapeutic option. Surgery of both eyes was performed consecutively within 1 week. Detailed descriptions and illustrations of the surgical steps and treatment outcome were provided and supplemented by a discussion of the current literature. The authors concluded that Graves' Ophthalmopathy is a variant and therapeutically challenging disease. Exceptional courses of the disease call for therapeutic approaches off the beaten track. Surgical extra-ocular muscle repositioning, which has not been described before in the context of Graves' Ophthalmopathy, proved to be effective in improving the patient's eyesight and quality of life (QOL). These preliminary findings need to be further investigated.